trial

Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.

NCTId NCT06505668
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 40 (estimated)
Sponsored by All India Institute of Medical Sciences, Bhubaneswar
Primary completion 2025-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2023-08-01
Primary completion
2025-06-30
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Atenolol 25 mgIvabradine 10mg

Sponsors

All India Institute of Medical Sciences, BhubaneswarLead Sponsor

Investigators

1
Biswa Ranjan Mishra, MDPrincipal Investigator

Sites

1 total
Bhubaneswar, India

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2025-06-30
Status
RECRUITING
relationships
The graph out of here
drug
Atenolol 25 mg
drug
Ivabradine 10mg
drug
lead_sponsor
All India Institute of Medical Sciences, Bhubaneswar
company
indication
Heart Rate Variability
indication
Treatment Resistant Schizophrenia
indication
Schizophrenia, Treatment-Resistant
indication
investigator
Biswa Ranjan Mishra, MD
person